China recalls capsules suspected of liver damage

BEIJING (Reuters) - China has ordered a hemorrhoid medicine off pharmacy shelves over fears the capsules were to blame for liver problems, state media reported on Wednesday.

The State Food and Drug Administration (SFDA) demanded the nationwide recall of the “Zhixue” capsules made by Vital Pharmaceutical Holdings Ltd in southwest China, Xinhua news agency reported.

Twenty-one people across the country suffered “liver problems” after taking the medicine in past months, and another 14 reported other problems, Xinhua reported.

But the notice posted on the SFDA website (www.sfda.gov.cn) on Tuesday said investigators were still trying to establish whether the pills caused the illness.

“A link between the Zhixue capsules and the liver damage cannot be ruled out,” said the notice. “More research needs to be done on the mechanism of occurrence,” it said.

Chinese-made products, including medicines, have been beset by flaws and toxins that have alarmed consumers at home and abroad. The country’s milk supply was at the heart of the latest scandal, over the unlawful use of the industrial chemical melamine, blamed for the deaths of four children.

Vital Pharmaceuticals has suspended production of the pills, and retailers and consumers have been asked to return them, said the official notice.

There was no mention in the report or notice of any of the pills being exported.

(Reporting by Chris Buckley; Editing by Ken Wills)

Source

--------------------------------------------------------------------------------------------
Related Posts:


BEIJING (Reuters) - China said on Friday it had recalled a batch of disposable medical needles after one snapped when inserted into an infant’s vein, the latest in a string of food and product safety problems. Health organizations were ordered to stop using the needles, made by a Shanghai-based firm, after tests on another six from

Full Post: China recalls needles that snapped in infant’s vein
--------------------------------------------------------------------------------------------

BEIJING (Reuters) - China has recalled a herbal remedy after it was blamed for the death of a newborn baby, state media said on Monday, in the latest health scare to hit the country. The 9-day-old baby in the northern province of Shaanxi died after being injected with “Yinzhihuang,” a remedy containing herbal extracts and used

Full Post: China recalls another herbal drug after baby death
--------------------------------------------------------------------------------------------

BEIJING (Reuters) - Three Chinese dairy companies have publicly apologized for their involvement in a toxic milk scandal that has killed at least four children and led to Chinese-made products pulled from shelves around the world. Inner Mongolia Yili Industrial Group, Mengniu Dairy and Bright Dairy Group were found earlier to have produced milk contaminated with

Full Post: China milk scandal companies apologize
--------------------------------------------------------------------------------------------

BEIJING (Reuters) - China, fighting a health scandal over melamine found in milk and other food products, now says it is investigating melamine tableware, following reports it might be harmful to health when hot. Quality inspectors told Xinhua news agency they were organizing tests of melamine tableware “following reports that some products contained poisonous ingredients.” Melamine is

Full Post: China now probes melamine tableware scare
--------------------------------------------------------------------------------------------

BEIJING (Reuters) - Chinese food and drug makers struggling in a declining economy could be tempted to cut corners and ignore quality standards, a senior Chinese official warned as the country awaits court verdicts in a tainted milk scandal. China has been rocked by a number of scandals in recent years involving unsafe food and drugs

Full Post: China warns of more health scares amid slowdown

Site Navigation

Most Read

Search